Wells Fargo & Company Argenx Se Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Argenx Se stock. As of the latest transaction made, Wells Fargo & Company holds 52,711 shares of ARGX stock, worth $33.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

52,711

Previous 45,562 15.69%

Holding current value

$33.7 Million

Previous $24.7 Million 31.19%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$520.52 - $638.33 $3.72 Million - $4.56 Million	7,149 Added 15.69%	52,711 $32.4 Million
Q3 2024 Nov 13, 2024	SELL	$434.22 - $551.9 $282,243 - $358,735	-650 Reduced 1.41%	45,562 $24.7 Million
Q2 2024 Aug 13, 2024	SELL	$356.01 - $451.55 $501,618 - $636,233	-1,409 Reduced 2.96%	46,212 $19.9 Million
Q1 2024 May 10, 2024	BUY	$356.95 - $413.29 $1.89 Million - $2.18 Million	5,286 Added 12.49%	47,621 $18.7 Million
Q4 2023 Feb 09, 2024	SELL	$338.91 - $506.01 $4.66 Million - $6.96 Million	-13,760 Reduced 24.53%	42,335 $16.1 Million
Q3 2023 Nov 13, 2023	BUY	$369.35 - $548.43 $10.7 Million - $15.8 Million	28,865 Added 106.0%	56,095 $27.6 Million
Q2 2023 Aug 15, 2023	BUY	$360.14 - $422.58 $135,412 - $158,890	376 Added 1.4%	27,230 $10.6 Million
Q1 2023 May 12, 2023	BUY	$334.23 - $403.65 $253,680 - $306,370	759 Added 2.91%	26,854 $10 Million
Q4 2022 Feb 13, 2023	SELL	$342.17 - $402.31 $71,855 - $84,485	-210 Reduced 0.8%	26,095 $9.89 Million
Q3 2022 Nov 14, 2022	SELL	$343.2 - $395.75 $3.34 Million - $3.85 Million	-9,718 Reduced 26.98%	26,305 $9.29 Million
Q2 2022 Aug 12, 2022	BUY	$269.58 - $378.88 $266,345 - $374,333	988 Added 2.82%	36,023 $13.6 Million
Q1 2022 May 16, 2022	BUY	$254.45 - $351.06 $1.29 Million - $1.78 Million	5,078 Added 16.95%	35,035 $11 Million
Q4 2021 Feb 14, 2022	SELL	$272.01 - $353.03 $164,294 - $213,230	-604 Reduced 1.98%	29,957 $10.5 Million
Q3 2021 Nov 15, 2021	BUY	$295.0 - $350.58 $2.05 Million - $2.44 Million	6,950 Added 29.44%	30,561 $9.23 Million
Q2 2021 Aug 16, 2021	SELL	$257.11 - $319.92 $901,427 - $1.12 Million	-3,506 Reduced 12.93%	23,611 $7.11 Million
Q1 2021 May 13, 2021	SELL	$268.3 - $380.31 $88,807 - $125,882	-331 Reduced 1.21%	27,117 $7.47 Million
Q4 2020 Feb 09, 2021	BUY	$248.13 - $308.36 $19,602 - $24,360	79 Added 0.29%	27,448 $8.07 Million
Q3 2020 Nov 05, 2020	BUY	$215.51 - $272.51 $721,096 - $911,818	3,346 Added 13.93%	27,369 $7.19 Million
Q2 2020 Aug 13, 2020	BUY	$127.44 - $232.72 $143,115 - $261,344	1,123 Added 4.9%	24,023 $5.41 Million
Q1 2020 May 14, 2020	BUY	$108.83 - $165.23 $2.49 Million - $3.78 Million	22,900 New	22,900 $3.02 Million

Others Institutions Holding ARGX

# of Institutions

424

Shares Held

29.4M

Call Options Held

338K

Put Options Held

347K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $35.4B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Argenx Se Transaction History